Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2005
Heparanase accelerates wound angiogenesis and wound healing in mouse and rat modelsEyal Zcharia, Rachel Zilka, Alon Yaar, et al.Biochemistry|August 14, 2002
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitorsBenito Casu, Marco Guerrini, Annamaria Naggi, et al.Seminars in Thrombosis and Hemostasis|July 17, 2007
O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasisMarjut Borgenström, Anni Wärri, Katri Hiilesvuo, et al.Journal of Medicinal Chemistry|January 22, 2005
Generation of "neoheparin" from E. coli K5 capsular polysaccharideUlf Lindahl, Jin-Ping Li, Marion Kusche-Gullberg, et al.Journal of Medicinal Chemistry|February 6, 2004
Undersulfated and glycol-split heparins endowed with antiangiogenic activityBenito Casu, Marco Guerrini, Sara Guglieri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axisJoseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, et al.Blood|May 31, 2007
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYang Yang, Veronica MacLeod, Yuemeng Dai, et al.Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.Pageof 4